Description
CJC-1295 without DAC, also known as Modified GRF (1-29), is a synthetic 29-amino-acid peptide derived from growth hormone-releasing hormone (GHRH). Its sequence is based on the amino-terminal GRF (1-29) fragment, with four amino-acid substitutions relative to the parent sequence.
The designation GRF (1-29) identifies the portion of the parent peptide represented by the chain. The modified sequence includes a D-configured alanine residue and additional substitutions within the backbone. Its C-terminus is amidated, meaning that the terminal group has an amide rather than a free carboxylic-acid format.
Without DAC identifies the non-conjugated format of this peptide. DAC stands for Drug Affinity Complex and describes an additional chemical group present in DAC-conjugated variants. A modified GRF peptide and a DAC-conjugated derivative therefore represent different molecular structures.
GHRH is itself a peptide distinct from growth hormone. Accordingly, CJC-1295 is described as a GHRH-derived analogue, rather than as a fragment of the growth hormone molecule.
For Research Purposes Only





















Reviews
There are no reviews yet.